Spirax-Sarco director takes Spectris CEO role, shares stay in focus on the LSE

Spirax-Sarco non-executive director Constance Baroudel will become CEO of Spectris from September while retaining her board seat, as the FTSE 100 group continues to target mid?single?digit organic growth and margin progression in 2026.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-22, 17:58.

Spirax-Sarco (GB00BWFGQN14) has reported stable trading and a boardroom development that keeps governance in focus for investors in London. The FTSE 100 industrial group trades on the London Stock Exchange, where it continues to be viewed as a benchmark UK engineering name.

What the latest trading update showed

In its most recent trading update for the four months to 30 April 2026, Spirax-Sarco reported mid-single-digit organic revenue growth at Group level, ahead of global Industrial Production trends, and reiterated its full-year 2026 guidance. The trading update on Investegate The company stated that adjusted operating profit margins progressed on an organic basis over the period, supported by pricing discipline and mix.

Net debt to EBITDA remained at around 1.5x, with net borrowings of approximately £575 million, which the company described as consistent with its balance sheet objectives. Details from the same trading statement Spirax-Sarco also proposed a final dividend of 121.1 pence per share, a 3 percent increase year-on-year, implying a cash outflow of about £89 million.

Board change with a wider FTSE link

On the governance side, Spirax-Sarco announced that non-executive director Constance Baroudel will leave her role at fellow FTSE engineering group Halma at the end of August 2026 to become Chief Executive Officer of Spectris Limited from 1 September 2026, while continuing as a director of Spirax-Sarco. Spirax-Sarco announcement on directorships The move strengthens the company’s network at the top end of the UK instrumentation and controls sector, which also includes peers such as Halma and Spectris.

According to consensus data compiled by MarketScreener, a majority of analysts currently rate Spirax-Sarco shares at Hold or equivalent, with a smaller group on Buy, reflecting the stock’s quality profile but also its premium valuation versus industrial peers. MarketScreener analyst consensus on Spirax-Sarco The consensus view anticipates continued mid-single-digit organic revenue growth and a modest uptick in adjusted operating margin through 2026.

How Spirax-Sarco makes its money

Spirax-Sarco generates most of its revenue from engineered solutions for the control and efficient use of steam and other industrial fluids in process plants worldwide. A representative offering is its Spirax Sarco steam trapping and condensate recovery systems, which help customers cut energy use and emissions in sectors such as food, pharmaceuticals and chemicals.

Where the shares trade today

The Spirax-Sarco shares (GB00BWFGQN14) trade on the London Stock Exchange under the ticker SPX; the latest verified quote and market capitalization are available on the LSE website and major financial data platforms.

Key data on the Spirax-Sarco shares

• Company: Spirax-Sarco Engineering plc
• ISIN: GB00BWFGQN14
• WKN: BWFGQN
• Ticker: SPX
• Trading venue: London Stock Exchange
• Price (as of latest available close): data available from LSE in GBP
• Market cap: data available from LSE in GBP (latest close)
• Sector / industry: Capital Goods / Industrial Machinery
• Index membership: FTSE 100
• Next earnings date: not officially scheduled

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities.